Medical Castration Using the Investigational Oral GnRH Antagonist TAK-385 (Relugolix): Phase 1 Study in Healthy Males. [electronic resource]
Producer: 20160418Description: 4579-87 p. digitalISSN:- 1945-7197
- Adult
- Aged
- Castration -- methods
- Dose-Response Relationship, Drug
- Double-Blind Method
- Food-Drug Interactions
- Gonadotropin-Releasing Hormone -- antagonists & inhibitors
- Humans
- Luteinizing Hormone -- blood
- Male
- Middle Aged
- Phenylurea Compounds -- adverse effects
- Prostatic Neoplasms -- drug therapy
- Pyrimidinones -- adverse effects
- Testosterone -- blood
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.